Funding for this research was provided by:
Received: 23 July 2020
Accepted: 29 September 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: The trial was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines and was approved by local authorities. An independent ethics committee or institutional review board approved the clinical protocol at every participating center. All patients provided written informed consent before study entry.
: Not applicable
: AC: Advisory Board membership: Abbott, Astra Zeneca, Eli Lilly, Janssen, Mundipharma, Novo Nordisk, OM Pharma. Lectures: Astra Zeneca, Berlin Chemie, Boehringer Ingelheim, Eli Lilly, Mundipharma, Novo Nordisk, Roche Diagnostics. Research Grants: Astra Zeneca, Eli Lilly, Mitsubishi, Novartis. AN has received honoraria from Novo Nordisk, Medtronic, AstraZeneca, Eli Lilly and Boheringer and research support from Novo Nordisk, Sanofi-Aventis, Pikdare, Shionogi, SOBI. APO, IZ, SK and JG are employees of Boehringer Ingelheim.